这是一篇来自已证抗体库的有关人类 CD147的综述,是根据42篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD147 抗体。
CD147 同义词: 5F7; CD147; EMMPRIN; EMPRIN; TCSF; basigin; OK blood group antigen; collagenase stimulatory factor; extracellular matrix metalloproteinase inducer; leukocyte activation antigen M6; tumor cell-derived collagenase stimulatory factor

圣克鲁斯生物技术
小鼠 单克隆(8D6)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术 CD147抗体(Santa Cruz Biotechnology Inc, sc-21746)被用于被用于免疫印迹在人类样品上 (图 2a). Blood Cancer J (2019) ncbi
小鼠 单克隆(F-5)
  • 免疫印迹; 人类; 1:300; 图 2C
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-374101)被用于被用于免疫印迹在人类样品上浓度为1:300 (图 2C). Oncol Lett (2017) ncbi
小鼠 单克隆(8D6)
  • 流式细胞仪; 人类; 图 2
  • 免疫沉淀; 人类; 图 2
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术 CD147抗体(Santa Cruz Biotechnology, sc-21746)被用于被用于流式细胞仪在人类样品上 (图 2), 被用于免疫沉淀在人类样品上 (图 2), 被用于免疫细胞化学在人类样品上 (图 2) 和 被用于免疫印迹在人类样品上浓度为1:200 (图 5). Nat Med (2016) ncbi
小鼠 单克隆(HIM6)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 CD147抗体(santa Cruz, sc-53693)被用于被用于免疫印迹在人类样品上 (图 1). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
圣克鲁斯生物技术 CD147抗体(santa Cruz, sc-71038)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图 1). Oncotarget (2015) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1c
圣克鲁斯生物技术 CD147抗体(Santa Cruz Biotechnology, sc-71038)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图 1c). BMC Cancer (2015) ncbi
小鼠 单克隆(8D6)
  • 免疫沉淀; 人类; 图 6a
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-21746)被用于被用于免疫沉淀在人类样品上 (图 6a). J Immunol (2015) ncbi
小鼠 单克隆(F-5)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-374101)被用于被用于免疫印迹在人类样品上 (图 5a). J Immunol (2015) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫细胞化学; 人类; 1:200; 图 1
  • 免疫组化; 人类; 1:400; 图 5
  • 免疫印迹; 人类; 1:500; 图 1
圣克鲁斯生物技术 CD147抗体(santa Cruz, sc-71038)被用于被用于免疫细胞化学在人类样品上浓度为1:200 (图 1), 被用于免疫组化在人类样品上浓度为1:400 (图 5) 和 被用于免疫印迹在人类样品上浓度为1:500 (图 1). Oncotarget (2015) ncbi
小鼠 单克隆(8D6)
  • 免疫组化; 人类; 1:100; 图 2
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-21746)被用于被用于免疫组化在人类样品上浓度为1:100 (图 2). J Urol (2015) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-71038)被用于被用于免疫细胞化学在人类样品上. J Cell Mol Med (2015) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
圣克鲁斯生物技术 CD147抗体(Santa Cruz Biotechnology, sc-71038)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图 1). BMC Cancer (2014) ncbi
小鼠 单克隆(1.BB.218)
  • 免疫印迹; 人类; 1:200; 图 4a
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-71038)被用于被用于免疫印迹在人类样品上浓度为1:200 (图 4a). Mol Carcinog (2015) ncbi
小鼠 单克隆(F-5)
  • 免疫印迹; 人类
圣克鲁斯生物技术 CD147抗体(Santa Cruz, sc-374101)被用于被用于免疫印迹在人类样品上. J Biomed Mater Res A (2015) ncbi
赛默飞世尔
小鼠 单克隆(MEM-M6/6)
  • 抑制或激活实验; 人类; 图 6d
赛默飞世尔 CD147抗体(Invitrogen, MEM6/6)被用于被用于抑制或激活实验在人类样品上 (图 6d). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(8D12)
  • 流式细胞仪; 人类; 图 6a
赛默飞世尔 CD147抗体(Affymetrix, 12-1472-42)被用于被用于流式细胞仪在人类样品上 (图 6a). Nat Commun (2017) ncbi
小鼠 单克隆(8D12)
  • 免疫细胞化学; 人类; 图 3a
赛默飞世尔 CD147抗体(eBiosciences, 8D12)被用于被用于免疫细胞化学在人类样品上 (图 3a). Mol Ther (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000; 图 1
赛默飞世尔 CD147抗体(Invitrogen, 34-5600)被用于被用于免疫印迹在人类样品上浓度为1:2000 (图 1). Oncol Lett (2016) ncbi
小鼠 单克隆(8D12)
  • 流式细胞仪; 人类; 1:100; 图 s10a
赛默飞世尔 CD147抗体(eBioscience, 8D12)被用于被用于流式细胞仪在人类样品上浓度为1:100 (图 s10a). Nat Med (2015) ncbi
小鼠 单克隆(8D12)
  • 流式细胞仪; 人类; 图 s4b
赛默飞世尔 CD147抗体(eBioscience, 8D12)被用于被用于流式细胞仪在人类样品上 (图 s4b). Nucleic Acids Res (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:500
赛默飞世尔 CD147抗体(Invitrogen, 34-5600)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:500. Tumour Biol (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:500; 图 2
  • 免疫印迹; 人类; 1:5000; 图 3
赛默飞世尔 CD147抗体(Invitrogen, 34-5600)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:500 (图 2) 和 被用于免疫印迹在人类样品上浓度为1:5000 (图 3). J Transl Med (2013) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 人类; 图 3
  • 免疫组化-冰冻切片; 小鼠; 图 2
赛默飞世尔 CD147抗体(Zymed, 34-5600)被用于被用于免疫组化-冰冻切片在人类样品上 (图 3) 和 被用于免疫组化-冰冻切片在小鼠样品上 (图 2). Brain (2013) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:250; 图 1
赛默飞世尔 CD147抗体(Invitrogen, 34-5600)被用于被用于免疫组化在人类样品上浓度为1:250 (图 1). Hum Pathol (2012) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 7
赛默飞世尔 CD147抗体(Zymed, 34-5600)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图 7). J Vis Exp (2011) ncbi
BioLegend
小鼠 单克隆(HIM6)
  • 免疫印迹; 人类; 图 5b
BioLegend CD147抗体(BioLegend, 306206)被用于被用于免疫印迹在人类样品上 (图 5b). J Immunol (2015) ncbi
小鼠 单克隆(HIM6)
  • 流式细胞仪; 人类; 图 5
BioLegend CD147抗体(Biolegend, 306209)被用于被用于流式细胞仪在人类样品上 (图 5). J Neuroinflammation (2015) ncbi
小鼠 单克隆(HIM6)
  • 免疫细胞化学; 人类; 1:200; 图 6c
BioLegend CD147抗体(Biolegend, HIM6)被用于被用于免疫细胞化学在人类样品上浓度为1:200 (图 6c). Nat Med (2015) ncbi
小鼠 单克隆(HIM6)
  • 免疫细胞化学; 人类
BioLegend CD147抗体(BioLegend, HIM6)被用于被用于免疫细胞化学在人类样品上. J Biol Chem (2015) ncbi
小鼠 单克隆(HIM6)
  • 流式细胞仪; 人类; 图 s4
BioLegend CD147抗体(BioLegend, 306207)被用于被用于流式细胞仪在人类样品上 (图 s4). J Mol Cell Biol (2015) ncbi
小鼠 单克隆(HIM6)
  • 免疫细胞化学; 人类; 1:1000; 图 2A
BioLegend CD147抗体(BioLegend, H1M6)被用于被用于免疫细胞化学在人类样品上浓度为1:1000 (图 2A). Mol Hum Reprod (2015) ncbi
安迪生物R&D
小鼠 单克隆(TRA-1-85)
  • 流式细胞仪; 人类; 图 1a
安迪生物R&D CD147抗体(R&D Systems, FAB3195N)被用于被用于流式细胞仪在人类样品上 (图 1a). Biol Open (2017) ncbi
山羊 多克隆
  • 其他; 人类; 100 ng/ml
安迪生物R&D CD147抗体(R&D, BAF972)被用于被用于其他在人类样品上浓度为100 ng/ml. Oncotarget (2016) ncbi
小鼠 单克隆(TRA-1-85)
  • 流式细胞仪; 人类
安迪生物R&D CD147抗体(R&D, clone TRA-1-85)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2014) ncbi
小鼠 单克隆(TRA-1-85)
  • 流式细胞仪; 人类; 1:50; 图 5
安迪生物R&D CD147抗体(R&D Systems, FAB3195A)被用于被用于流式细胞仪在人类样品上浓度为1:50 (图 5). Nat Commun (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(MEM-M6/1)
  • 免疫组化-石蜡切片; 人类; 图 3
艾博抗(上海)贸易有限公司 CD147抗体(Abcam, ab666)被用于被用于免疫组化-石蜡切片在人类样品上 (图 3). Eur J Rheumatol (2016) ncbi
兔 单克隆(EPR4052)
  • 免疫细胞化学; 大鼠; 图 5
艾博抗(上海)贸易有限公司 CD147抗体(Abcam, ab108317)被用于被用于免疫细胞化学在大鼠样品上 (图 5). Front Cell Neurosci (2015) ncbi
小鼠 单克隆(MEM-M6/1)
  • 免疫组化-冰冻切片; 人类; 图 2
  • 免疫组化-石蜡切片; 人类; 图 5
艾博抗(上海)贸易有限公司 CD147抗体(Abcam, MEM-M6/1)被用于被用于免疫组化-冰冻切片在人类样品上 (图 2) 和 被用于免疫组化-石蜡切片在人类样品上 (图 5). PLoS ONE (2014) ncbi
兔 单克隆(EPR4052)
  • 免疫印迹; 人类; 图 6a
艾博抗(上海)贸易有限公司 CD147抗体(Abcam, ab108317)被用于被用于免疫印迹在人类样品上 (图 6a). BMC Biol (2014) ncbi
LifeSpan Biosciences
小鼠 单克隆
  • 免疫组化; 人类; 1:500; 图 2
LifeSpan Biosciences CD147抗体(LS Biosciences, LS-B3163)被用于被用于免疫组化在人类样品上浓度为1:500 (图 2). Leukemia (2016) ncbi
小鼠 单克隆(MEM-M6/1)
  • 免疫组化; 人类; 1:300; 图 5f
LifeSpan Biosciences CD147抗体(LifeSpan BioSciences, MEM-M6-1)被用于被用于免疫组化在人类样品上浓度为1:300 (图 5f). Nat Med (2015) ncbi
碧迪BD
小鼠 单克隆(HIM6)
  • 免疫印迹; 人类; 图 4f
碧迪BD CD147抗体(BD, 555961)被用于被用于免疫印迹在人类样品上 (图 4f). Oncogene (2018) ncbi
小鼠 单克隆(HIM6)
  • 流式细胞仪; 人类; 图 3e
  • 免疫沉淀; 人类; 图 3a
  • 免疫细胞化学; 人类; 图 3c
  • 免疫印迹; 人类; 图 2a
碧迪BD CD147抗体(BD Biosciences, 555962)被用于被用于流式细胞仪在人类样品上 (图 3e), 被用于免疫沉淀在人类样品上 (图 3a), 被用于免疫细胞化学在人类样品上 (图 3c) 和 被用于免疫印迹在人类样品上 (图 2a). Exp Cell Res (2017) ncbi
小鼠 单克隆(HIM6)
  • 流式细胞仪; 人类; 图 s9
碧迪BD CD147抗体(BD Pharmingen, HIM6)被用于被用于流式细胞仪在人类样品上 (图 s9). Nat Med (2016) ncbi
小鼠 单克隆(HIM6)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD147抗体(BD, 555962)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(HIM6)
  • proximity ligation assay; 人类; 1:250; 图 8
  • 免疫印迹; 人类; 图 5
碧迪BD CD147抗体(BD-Pharmingen, 555961)被用于被用于proximity ligation assay在人类样品上浓度为1:250 (图 8) 和 被用于免疫印迹在人类样品上 (图 5). Oncotarget (2015) ncbi
默克密理博中国
小鼠 单克隆(1S9-2A)
  • 抑制或激活实验; 小鼠; 图 s5i
默克密理博中国 CD147抗体(Millipore, 1S9-2A)被用于被用于抑制或激活实验在小鼠样品上 (图 s5i). Proc Natl Acad Sci U S A (2016) ncbi
文章列表
  1. Zhu Y, Shi C, Bruins L, Wang X, Riggs D, Porter B, et al. Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood Cancer J. 2019;9:19 pubmed 出版商
  2. Dai L, Del Valle L, Miley W, Whitby D, Ochoa A, Flemington E, et al. Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. Oncogene. 2018;37:4534-4545 pubmed 出版商
  3. Kanjee U, Grüring C, Chaand M, Lin K, Egan E, Manzo J, et al. CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of Plasmodium falciparum invasion. Proc Natl Acad Sci U S A. 2017;114:E9356-E9365 pubmed 出版商
  4. Huang N, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun. 2017;8:423 pubmed 出版商
  5. Zhou Y, Wu B, Li J, Nan G, Jiang J, Chen Z. Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion. Exp Cell Res. 2017;357:9-16 pubmed 出版商
  6. Yang S, Qi F, Tang C, Wang H, Qin H, Li X, et al. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells. Oncol Lett. 2017;13:898-904 pubmed 出版商
  7. Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed 出版商
  8. Badillo Soto M, Rodríguez Rodríguez M, Pérez Pérez M, Daza Benítez L, Bollain Y Goytia J, Carrillo Jiménez M, et al. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning. Eur J Rheumatol. 2016;3:44-49 pubmed
  9. Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. 2016;7:59877-59891 pubmed 出版商
  10. Marshall D, Harried S, Murphy J, Hall C, Shekhani M, Pain C, et al. Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins. Mol Ther. 2016;24:1760-1770 pubmed 出版商
  11. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed 出版商
  12. Hatanaka M, Higashi Y, Kawai K, Su J, Zeng W, Chen X, et al. CD147-targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation. Oncol Lett. 2016;11:2424-2428 pubmed
  13. Krampitz G, George B, Willingham S, Volkmer J, Weiskopf K, Jahchan N, et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A. 2016;113:4464-9 pubmed 出版商
  14. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  15. Ronquist K, Sanchez C, Dubois L, Chioureas D, Fonseca P, Larsson A, et al. Energy-requiring uptake of prostasomes and PC3 cell-derived exosomes into non-malignant and malignant cells. J Extracell Vesicles. 2016;5:29877 pubmed 出版商
  16. Heller J, Kwok J, Vecino E, Martin K, Fawcett J. A Method for the Isolation and Culture of Adult Rat Retinal Pigment Epithelial (RPE) Cells to Study Retinal Diseases. Front Cell Neurosci. 2015;9:449 pubmed 出版商
  17. Pinheiro C, Granja S, Longatto Filho A, Faria A, Fragoso M, Lovisolo S, et al. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors. Oncotarget. 2015;6:44403-21 pubmed 出版商
  18. Pinheiro C, Garcia E, Morais Santos F, Moreira M, Almeida F, Jubé L, et al. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. BMC Cancer. 2015;15:835 pubmed 出版商
  19. Bhat N, Adams C, Chen Y, Bieber M, Teng N. Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies. J Immunol. 2015;195:5178-88 pubmed 出版商
  20. Morais Santos F, Granja S, Miranda Gonçalves V, Moreira A, Queirós S, Vilaça J, et al. Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget. 2015;6:19177-89 pubmed
  21. Panchabhai S, Kelemen K, Ahmann G, Sebastian S, Mantei J, Fonseca R. Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma. Leukemia. 2016;30:951-4 pubmed 出版商
  22. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed 出版商
  23. Hemdan T, Malmström P, Jahnson S, Segersten U. Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study. J Urol. 2015;194:1575-81 pubmed 出版商
  24. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed 出版商
  25. Naito T, Takatsu H, Miyano R, Takada N, Nakayama K, Shin H. Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics. J Biol Chem. 2015;290:15004-17 pubmed 出版商
  26. Khayati F, Pérez Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak M, et al. EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. Oncotarget. 2015;6:9766-80 pubmed
  27. Valença I, Pértega Gomes N, Vizcaino J, Henrique R, Lopes C, Baltazar F, et al. Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. J Cell Mol Med. 2015;19:723-33 pubmed 出版商
  28. Menck K, Scharf C, Bleckmann A, Dyck L, Rost U, Wenzel D, et al. Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN. J Mol Cell Biol. 2015;7:143-53 pubmed 出版商
  29. Byrne S, Ortiz L, Mali P, Aach J, Church G. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43:e21 pubmed 出版商
  30. Pinheiro C, Garcia E, Morais Santos F, Scapulatempo Neto C, Mafra A, Steenbergen R, et al. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:751 pubmed 出版商
  31. Afonso J, Santos L, Miranda Gonçalves V, Morais A, Amaro T, Longatto Filho A, et al. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance. Mol Carcinog. 2015;54:1451-66 pubmed 出版商
  32. Singh H, Aplin J. Endometrial apical glycoproteomic analysis reveals roles for cadherin 6, desmoglein-2 and plexin b2 in epithelial integrity. Mol Hum Reprod. 2015;21:81-94 pubmed 出版商
  33. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed 出版商
  34. Calabro S, Maczurek A, Morgan A, Tu T, Wen V, Yee C, et al. Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS ONE. 2014;9:e90571 pubmed 出版商
  35. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed 出版商
  36. Liu G, Suzuki K, Li M, Qu J, Montserrat N, Tarantino C, et al. Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun. 2014;5:4330 pubmed 出版商
  37. Baron Y, Pedrioli P, Tyagi K, Johnson C, Wood N, Fountaine D, et al. VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase. BMC Biol. 2014;12:39 pubmed 出版商
  38. Futamura N, Nishida Y, Urakawa H, Kozawa E, Ikuta K, Hamada S, et al. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. Tumour Biol. 2014;35:5159-65 pubmed 出版商
  39. Rabien A, Stephan C, Kilic E, Weichert W, Kristiansen G, Miller K, et al. Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis. J Transl Med. 2013;11:258 pubmed 出版商
  40. Agrawal S, Williamson J, Sharma R, Kebir H, Patel K, Prat A, et al. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis. Brain. 2013;136:1760-77 pubmed 出版商
  41. Stenzinger A, Wittschieber D, von Winterfeld M, Goeppert B, Kamphues C, Weichert W, et al. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer. Hum Pathol. 2012;43:1471-81 pubmed 出版商
  42. Gatesman Ammer A, Hayes K, Martin K, Zhang L, Spirou G, Weed S. Multi-photon imaging of tumor cell invasion in an orthotopic mouse model of oral squamous cell carcinoma. J Vis Exp. 2011;: pubmed 出版商